TLR2 and synucleinopathy: We have previously shown that α-synuclein oligomers propagate from neuron to glial cells engaging the TLR2 and promoting inflammation which reduced in the TLR2 knockout background [8], however it is unclear if immunotherapy with TLR2 antibodies might rescue the complex pathology in models of synucleinopathy.